A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots
A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech's application to offer booster shots to...
Full Article
A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots
Upworthy
0 shares
1 views
You might like
Related news coverage
Pfizer Starts Clinical Trial of COVID Prevention Drug
VOA News
Drugmaker Pfizer said it has started a large-scale clinical trial of a drug to ward off COVID-19 in those who are exposed to the..
Advertisement
More coverage
CDC Endorses COVID Booster For Millions Of Older, High-Risk Americans
Newsy
Watch VideoThe CDC endorsed booster shots for millions of older or otherwise vulnerable Americans on Thursday, opening a major new..